american diabetes association history of pancreatitis glp-1 receptor agonist The Use Glucagon-like Peptide-1 Agonists in Patients with Type 2 Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study GLP-1 Agonists and Pancreatitis Risk
Description
Two FDA-approved ways to lose weight with Wegovy Oral or injectable options, personalized to your goals and lifestyle, with care from a licensed healthcare provider
Idf Diabetes Atlas
T., Batterham, R
Implications for employers: GLP-1 medications can cause GI problems and that is why starting doses are gradually increased
3840 Orally bioavailable small-molecule GLP-1RAs are in early development, offering potential for once-daily administration
Whether the same will extend to humans remains to be seen, but the authors claim their study "provides a strategy for diabetes prevention." The study was published in Nature Microbiology
